GVR Report cover Pet Obesity Management Market Size, Share & Trends Report

Pet Obesity Management Market Size, Share & Trends Analysis Report By Product (Drugs, Food Supplements), By Animal Type (Dogs, Cats), By End Use (Pet Specialty Stores, E-commerce), And Segment Forecasts, 2019 - 2026

  • Report ID: GVR-2-68038-888-6
  • Number of Pages: 100
  • Format: Electronic (PDF)
  • Historical Range: 2015 - 2017
  • Industry: Healthcare

Report Overview

The global pet obesity management market size was valued at USD 626.99 million in 2018 and is expected to register a CAGR of 6.8% over the forecast period. Rising need to curb pet obesity, as obesity increases the risk of other chronic conditions, such as osteoarthritis and diabetes, is expected to provide growth platform to the market. According to an APOP report, in 2017, 56% of dogs and 60% of cats were overweight or obese in the U.S.

North America pet obesity management market

Moreover, growing pet adoption and increasing per capita income levels, especially in developing countries, are expected to accelerate the growth of this market. Rising cases of pet obesity-related diseases is further expected to boost the demand for obesity management in pets, thereby augmenting the market growth.

For instance, average treatment fee for arthritis, which is aggravated due to excessive weight, was USD 310.0 in 2016. Thus, rising concerns among pet owners to manage the excess weight of companion animals at the early stage is one of the major drivers for this market. Increasing number of companion ownership is also expected to fuel the market development in the years to come.

According to American Veterinary Medical Association (AVMA) pet ownership is on the rise in the U.S. with dogs animal type segment leading the market. It is highest in rural areas and lowest in urban states. For instance, according to a survey conducted by APPA in 2017, 85 million households in the U.S. had pets. Moreover, in 2017, the U.S. pet industry expenditure was estimated at USD 69.5 million.

Product Insights

Food supplements segment accounted for the largest market in 2018 due to the lack of branded pet drugs in the market. The segment will expand further as pet owners rely on food supplements and exercise than drugs for obesity management. Rising need for healthy, organic, and nutritious food products is anticipated to boost the segment growth further. With changing lifestyles, consumers are spending more on quality pet foods.

Increasing incidence of pet obesity and the resultant rise in the number of osteoarthritis cases is also boosting the demand for food supplements for weight management. According to a report by Kingsbrook Vets, 20% of all dogs, regardless of their ages, in the U.S. had osteoarthritis in 2017. On the contrary, Policies levied by Drug Price Control (DPCO) units prevent veterinary pharmaceutical companies from generating an investible surplus.

This results in entry barriers for new companies, thereby hindering the market growth. High demand for weight management programs where proper exercise and meals are prescribed by veterinarians will drive the segment further. The drugs segment is projected to expand at the highest CAGR from 2019 to 2026 as in some cases, drugs are also prescribed if the obesity is not manageable with exercise and meals. Some medicines, which are used as off-label, are Orlistat by Glaxo smith cline, Saxenda by Novo Nordisk, Belviq by Arena Pharmaceuticals, etc.

Animal Type Insights

Dogs animal type segment accounted for the largest market share in 2018 due to increased animal healthcare spending, specifically in the developed regions. According to APPA, companion animal spending has been consistently on the rise and was valued at USD 72.56 billion in 2017. The cats segment is anticipated to witness the fastest growth throughout the forecast period due to high preference for cats over dogs. According to AAPA reports, around 47.1 households had cats in 2017 and around 59% of the cats in the U.S. were obese.

End-Use Insights

E-commerce segment is expected to lead the market over the forecast years due to easy availability of pet food supplements on online portals. Moreover, these portals offer products at discounted prices. Moreover, rising penetration of smartphones and internet providing accessibility to the remote locations in developing economies, such as India and China, are further anticipated to increase the usage of ecommerce platforms.

Global pet obesity management market

Some common websites offering pet food supplements and drugs include Amazon, BuyWow, and 1mg.The others segment includes hospitals and veterinary clinics. It is expected to witness the maximum growth rate from 2019 to 2026 due to increased number of pet clinic visits. Moreover, the availability of a wide range of treatments and surgeries in these facilities will drive segment further.

Regional Insights

North America captured the largest market share in 2018. Almost, 25 to 30% of general canine population was suffering from obesity in the region. Rising pet ownership is expected to drive the regional market further. According to an AAPA report published in 2017, ~60.2 million U.S. households had at least one dog.

Favorable insurance policies are further anticipated to widen the scope for market growth. Moreover, rising concerns among pet owners regarding the associated risks of obesity is augmenting the demand for efficient weight management program, which is also projected to boost market. According to an AAPA report, the total expenditure of the pet industry was USD 69.4 billion in 2017 in the U.S.

Asia Pacific is expected to be the fastest-growing regional market over the forecast period. This growth is attributed to rising pet adoption in emerging economies like India, which is one of the most lucrative markets due to government efforts to improve veterinary healthcare facilities and various funding schemes delivered by the national as well as state governments. As per a report published in 2016 by Open Government Data Platform (Government of India), the country had 11,367 veterinary hospitals/polyclinics.

Key Companies & Market Share Insights

The industry is highly competitive and is marked by the presence of various small- and large-scale companies. Some of the prominent companies in the global market include Royal Canin; Hills Pet Nutrition, Inc.; and Pedigree. These companies focus on new product development and expansion of their distribution channels to capture a larger market share.

They are inclined toward maintaining strong competition by fulfilling unmet needs by delivering economic products. They are also consistently trying to boost their profits through mergers and acquisitions, geographical expansion, etc. For instance, in May 2018 Royal Canin partnered with Celebrity Alison Sweeny on their “Fight the Beg” capaign to address pet obesity.

Pet Obesity Management Market Report Scope 

Report Attribute


Market size value in 2020

USD 693.92 million

Revenue forecast in 2026

USD 1.04 billion

Growth Rate

CAGR of 6.8% from 2019 to 2026

Base year for estimation


Historical data

2015 - 2017

Forecast period

2019 - 2026

Quantitative units

Revenue in USD million and CAGR from 2019 to 2026

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Product, animal type, end-use, region

Regional scope

North America; Europe, Asia Pacific; Latin America; MEA

Country scope

U.S.; Canada; U.K.; Germany; Italy; France; Spain; Japan; China; India; Mexico; Brazil; Argentina; South Africa; Saudi Arabia

Key companies profiled

Pfizer animal health; Novo Nordisk A/S; Royal Canin; Vivaldis; Pedigree; Hills Pet Nutrition; Auxthera LLC

Customization scope

Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Segments Covered in the Report

This report forecasts revenue and volume growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2015 to 2026. For the purpose of this study, Grand View Research has segmented the global pet obesity management market report on the basis of product, animal type, end use, and region:

  • Product Outlook (Revenue, USD Million, 2015 - 2026)

    • Drugs

    • Food Supplements

  • Animal Type Outlook (Revenue, USD Million, 2015 - 2026)

    • Dogs

    • Cats

  • End Use Outlook (Revenue, USD Million, 2015 - 2026)

    • Pet Specialty Stores

    • E-commerce

    • Others

  • Regional Outlook (Revenue, USD Million, 2015 - 2026)

    • North America

      • The U.S.

      • Canada

    • Europe

      • The U.K.

      • Germany

      • France

      • Italy

      • Spain

    • Asia Pacific

      • Japan

      • China

      • India

    • Latin America

      • Mexico

      • Brazil

      • Argentina

    • Middle East & Africa

      • South Africa

      • Saudi Arabia

Frequently Asked Questions About This Report

gvr icn


gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

gvr icn


We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now

ESOMAR Certified Member Great Place to Work Certified

ESOMAR & Great Work to Place Certified

ISO 9001:2015 & 27001:2022 Certified

ISO 9001:2015 & 27001:2022 Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.